CAS 229971-81-7

Exherin

Description:

Exherin, with the CAS number 229971-81-7, is a synthetic peptide that has garnered attention in the field of cancer research, particularly for its potential therapeutic applications. It is derived from the natural protein E-cadherin, which plays a crucial role in cell adhesion and maintaining tissue architecture. Exherin functions primarily as an antagonist of the E-cadherin-mediated cell adhesion, thereby disrupting the interactions between cancer cells and their surrounding microenvironment. This disruption can inhibit tumor growth and metastasis, making Exherin a candidate for targeted cancer therapies. The substance is typically characterized by its peptide structure, which allows it to interact specifically with cellular receptors. In preclinical studies, Exherin has shown promise in enhancing the efficacy of other anticancer agents, although further research is necessary to fully understand its mechanisms and optimize its therapeutic potential. As with many experimental compounds, safety and efficacy in humans are critical areas of ongoing investigation.

Synonyms:

• Exherin TFA

ADH 1

CAS: 229971-81-7

Formula: C₂₂H₃₄N₈O₆S₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 570.6854

Ref: IN-DA00BF5Y

(4R,7S,10S,13S,16R)-13-((1H-Imidazol-5-Yl)Methyl)-16-Acetamido-7-Isopropyl-10-Methyl-6,9,12,15-Tetraoxo-1,2-Dithia-5,8,11,14-Tetraazacycloheptadecane-4-Carboxamide

CAS: 229971-81-7

(4R,7S,10S,13S,16R)-13-((1H-Imidazol-5-Yl)Methyl)-16-Acetamido-7-Isopropyl-10-Methyl-6,9,12,15-Tetraoxo-1,2-Dithia-5,8,11,14-Tetraazacycloheptadecane-4-Carboxamide

Purity: 98%

Molecular weight: 570.69g/mol

Ref: 54-OR1026171

ADH-1

CAS: 229971-81-7

ADH-1 (Exherin) is an N-cadherin antagonist, inhibits N-cadherin mediated cell adhesion with potential antineoplastic and antiangiogenic activities.

Formula: C₂₂H₃₄N₈O₆S₂

Purity: 99.94%

Color and Shape: Solid

Molecular weight: 570.69

Ref: TM-T2637